Cardiological Healthcare
The Cardiovascular devices market is expected to register a CAGR of 6.4% over the forecast period. The emergence of the COVID-19 pandemic hurt the cardiovascular devices market in the beginning. It had a detrimental effect on the market due to the reduction in the diagnosis of cardiovascular diseases due to healthcare resources being reserved for COVID patients. For instance, as per the 2022 annual report of Medtronic a technology company having a major share of the revenue from the cardiovascular portfolio has increased revenue due to the global procedure volumes recovering from the decline brought on by the COVID-19 pandemic. Moreover, technologies used in the development of cardiology devices have improved significantly over the past decade, and indications for these devices have expanded.